Showing results (1-10 of 578) with videos related to
Sort By:
Pageof 58
Der Nervenarzt|September 24, 2025
[Dementia: changes from ICD-10 to ICD-11. German Version]Frank Jessen, Karl BroichInternational Psychogeriatrics|April 17, 2007
Outcome measures in clinical trials on medicinal products for the treatment of dementia: a European regulatory perspectiveKarl BroichInternational Psychogeriatrics|September 30, 2005
Regulatory issues in vascular dementia: a European perspectiveKarl BroichEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 10, 2009
Committee for Medicinal Products for Human Use (CHMP) assessment on efficacy of antidepressantsKarl Broich, Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|May 14, 2013
[Cancer: Is it really so different? Particularities of oncologic drugs from the perspective of the pharmaceutical regulatory agency]Harald Enzmann, Karl BroichDer Nervenarzt|August 18, 2025
[Digital health applications from a regulatory perspective-Experiences and current developments]Florian Strauch, Karl BroichThrombosis and Haemostasis|September 28, 2006
Selective COX-2 inhibitors and risk of thromboembolic events - regulatory aspectsHans-Karl Heim, Karl BroichEuropean Archives of Psychiatry and Clinical Neuroscience|November 6, 2009
Principle standards and problems regarding proof of efficacy in clinical psychopharmacologyHans-Jürgen Möller, Karl BroichBiomarkers in Medicine|September 24, 2016
The new EU regulation on in vitro diagnostics: potential issues at the interface of medicines and companion diagnosticsHarald Enzmann, Ralf Meyer, Karl BroichPageof 58